![Markus Loeffler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Markus Loeffler
Technik-/Wissenschafts-/F&E-Leiter bei NH THERAGUIX SAS
Profil
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Aktive Positionen von Markus Loeffler
Unternehmen | Position | Beginn |
---|---|---|
NH THERAGUIX SAS | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ausbildung von Markus Loeffler
INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
NH TherAguix SAS
![]() NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |